Abstract:Transforming growth factor-beta (TGF-beta) is known to be a potent inducer of stem cell chondrogenic differentiation. Transforming growth factor-beta/activin/nodal-signaling pathway has also been shown to be involved in maintaining the pluripotency of embryonic stem cells (ESCs). In this study, the effect of TGF-beta 1 in chondrogenic differentiation of ESCs was examined both with undifferentiated ESCs that bypassed classical embryoid body (EB) formation, and on 5-day EB-derived cells. The effect of TGF-beta 1 was compared to cells differentiated in serum-free chondrogenic basal medium without growth factor supplement. Analysis by real-time polymerase chain reaction (PCR), type II collagen enzyme-linked immunosorbent assay, sulfated glycoaminoglycan quantification and fluorescence immunostaining demonstrated substantial chondrogenic differentiation of ESCs regardless of EB formation in the absence of the growth factor. Addition of TGF-beta 1 significantly inhibited chondrogenic gene expression and collagen deposition with a more potent effect on the cells that bypassed EB formation. Our study using a TGF-beta/activin/nodal-signaling inhibitor suggested that TGF-beta inhibited early chondrogenic induction but was required at the later stage of differentiation, which was also reflected in the enhancing effect of TGF-beta 1 on chondrogenic development at later time points in EB-derived cells. Analysis of the pluripotency markers demonstrated sustained Oct4 and Nanog expression in the presence of TGF-beta 1 with Oct4-positive cells detected in subpopulations of the differentiated culture. Our results suggest that TGF-beta 1 suppresses ESC chondrogenic induction and the degree of suppression is dependent on the differentiation-stage of the ESC. Transforming growth factor-beta signaling, however, is required for functional chondrogenic development of ESC. Our finding that TGF-beta can sustain an undifferentiated population of human ESCs within the differentiation culture suggests that caution should be exercised when using this growth factor as an ESC chondrogenic inducer and highlights the importance of a selection protocol for chondroprogenitor cells to avoid possible teratoma formation in vivo.

TGF‐β1 Promotes Gap Junctions Formation in Chondrocytes Via Smad3/Smad4 Signalling

TGF-β2 Increases Cell-Cell Communication in Chondrocytes Via P-Smad3 Signalling.

TGF-β3 enhances cell-to-cell communication in chondrocytes via the ALK5/p-Smad3 axis

The involvement of the ERK-MAPK pathway in TGF-β1-mediated connexin43-gap junction formation in chondrocytes.

Stage-dependent effect of TGF-beta1 on chondrogenic differentiation of human embryonic stem cells.

CTGF facilitates cell‐cell communication in chondrocytes via PI3K/Akt signalling pathway

Transforming growth factor-β1-induced N-cadherin drives cell–cell communication through connexin43 in osteoblast lineage

Role of Integrin ß1 and Tenascin C Mediate TGF-SMAD2/3 Signaling in Chondrogenic Differentiation of BMSCs Induced by Type I Collagen Hydrogel

IL-10 Enhances Cell-to-cell Communication in Chondrocytes Via STAT3 Signaling Pathway.

Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta

Growth differentiation factor 5 modulation of chondrogenesis of self-assembled constructs involves gap junction-mediated intercellular communication.

Tgf Beta 1 Induces Hypertrophic Change And Expression Of Angiogenic Factors In Human Chondrocytes

Function and Regulation of Transforming Growth Factor Β1 Signalling in Antler Chondrocyte Proliferation and Differentiation.

TGF-β Induces Up-Regulation of Chondroitin Sulfate Synthase 1 (CHSY1) in Nucleus Pulposus Cells Through MAPK Signaling

RhoA/Rho Kinase Signaling Regulates Transforming Growth Factor-Β1-induced Chondrogenesis and Actin Organization of Synovium-Derived Mesenchymal Stem Cells Through Interaction with the Smad Pathway

TGF‐β/SMAD signaling inhibits intermittent cyclic mechanical tension‐induced degeneration of endplate chondrocytes by regulating the miR‐455‐5p/RUNX2 axis

CTGF Regulates Mineralization in Human Mature Chondrocyte by Controlling Pit-1 and Modulating ANK Via the BMP/Smad Signalling

Transforming Growth Factor-Beta L Induces Type Ii Collagen And Aggrecan Expression Via Activation Of Extracellular Signal-Regulated Kinase 1/2 And Smad2/3 Signaling Pathways

Transforming growth factor-beta1 inhibits tissue engineering cartilage absorption via inducing the generation of regulatory T cells.

Transforming Growth Factor-β Stimulates Cyclin D1 Expression Through Activation of Β-Catenin Signaling in Chondrocytes

Tgf-Stimulates Expression Of Chondroitin Polymerizing Factor In Nucleus Pulposus Cells Through The Smad3, Rhoa/Rock1, And Mapk Signaling Pathways